SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  RESOURCE CENTER  
  JOBS  
  SUBSCRIBE  
 RSS
  Tuesday, March 23, 2010 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

PRIME NEWS
TaiGen's DFI drug meets primary endpoint in phase II
Taiwan's TaiGen Biotechnology said that the phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability
Teijin Pharma launches drug for Hyperuricemia in Gout Pati
Teijin Pharma has launched TMX-67 (febuxostat), a novel drug for the treatment of hyperuricemia in patients with gout in Europe
TODAY'S NEWS
  Matrix, PharmaVentures sign MoU
  YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
  BioTeks Synergy H4 Hybrid Reader gets Transcreener approval
  Over 150 healthcare leaders to identify priorities for reform in Asia
  CordLife wins award in Mother, Baby & Child Expo 2010
  Valeant to buy branded generics company in Brazil
Advertisement
 
Digital Mag
Read on some of the best articles published in 2009

Issue: February, 2010
Current Issue
View / Download
Top Story
India puts bt brinjal on hold
 
 
 
Print Edition
Issue: March 2010
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement













 

NEWS
TaiGen's DFI drug meets primary endpoint in phase II
Taiwan's TaiGen Biotechnology said that the phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability
Teijin Pharma launches drug for Hyperuricemia in Gout Pati
Teijin Pharma has launched TMX-67 (febuxostat), a novel drug for the treatment of hyperuricemia in patients with gout in Europe
FEATURES
BioSpectrum Top 20: Taiwan
Taiwans pharmaceutical industry is expected to touch $1.86 billion in 2008 up from $1.84 billion in 2007. The increasingly fierce competition and declining margins of pharmaceutical brands in Taiwan are said to be the cause of this weak production value growth of local pharmaceutical industry.
Mixing protein engineering, chemistry for new drugs
Almost a decade ago, when Dr Ko-Chung Lin was working with Biogen as head of drug discovery in Boston, a few high ranking government officials from Taiwan visited the city
PEOPLE
NCKU President honored with Lifetime Achievement award
Dr Michael Ming-Chiao Lai, was presented with the 2009 Lifetime Achievement Award for his exceptional achievements in molecular virology, especially in hepatitis and coronavirus
We have people, projects, money and infrastructure
FOUNDED in 1973, the Industrial Technology Research Institute (ITRI) is a primary R&D center for industry in Taiwan. Back then, there were very few high-tech industries in Taiwan. Today, Taiwan is known for its ICT industries
EVENTS
Medical electronics market to reach $90bn in 2010
The size of the global medical electronics market in 2010 is poised to reach $90bn. It is with this in mind that the Ministry of Economic Affairs (MOEA)s Industrial Development Bureau is sponsoring the 2009 Medical Electronics in Taiwan forum
BioBusiness Asia 2009 opens in Taipei
The eighth BioBusiness Asia conference, a two-day gathering of life science business professionals from around Asia held annually in Taipei, Taiwan, opened Tuesday
R & D
Molecular biologists report new immune tolerance mechanism
Dr Ming-Zong Lai, a Research Fellow at the Institute of Molecular Biology, Academia Sinica and his colleagues have discovered that a molecule called "Deltex1", which is said to contribute to immune tolerance
NCKU unveils pocket-sized breast cancer detector
According to the University, the device, whose size is similar to an iPhone, was invented using near-infrared technology and is intended for the early detection and warning of breast cancer
POLICIES
Taiwan approves PharmiGene's DNA detection kit
PharmiGene, a pharmacogenetic-based molecular diagnostic company, has received approval from the Department of Health (DOH) in Taiwan to begin marketing the PG 1502 DNA detection kit, one in the line of the company's rapid genetic tests
Taiwan government revamps pharma regulations
Taiwan's Science and Technology Advisory Board has implemented key changes in the drug regulations to increase foreign pharmaceutical and biotechnology companies foray into Taiwan
PRODUCTS
Seahorse Bioscience appoints Cell-Bio as distributor in Taiwan
Headquartered in North Billerica, MA, Seahorse Bioscience, the leader in the design and development of instruments for assessing cellular bioenergetics, announced Cell-Bio Biotechnology as the distributor of Seahorse XF Analyzers and consumables
Teijin licenses gout drug to Astellas in Taiwan
Teijin Pharma has signed an exclusive distributorship agreement with Astellas Pharma Taiwan, the Taiwanese sales and marketing arm of Tokyo-based Astellas Pharma, regarding the marketing of TMX-67 in Taiwan
TRENDS & ANALYSIS
Blood Pressure Monitors gaining popularity in Taiwan
According to GfK Retail and Technology, healthcare has been receiving more attention in Taiwan and as a result, Personal Diagnostic products such as Blood Pressure Monitors (BPM) have had more focus in recent years
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black